Yahoo Web Search

Search results

1. • 

     3 No-Brainer Stocks to Buy in June

     Motley Fool via Yahoo Finance· 3 days ago

     The U.K.-based pharmaceutical giant can be an excellent fit for any type of portfolio. It pays a dividend of around...expects to get its top line to $80...

2. • 

     AbbVie (ABBV) Soars 3.2%: Is Further Upside Left in the Stock?

     Zacks via Yahoo Finance· 2 days ago

     AbbVie (ABBV) saw its shares surge in the last session with trading volume being higher than...

3. • 

     Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?

     Zacks via Yahoo Finance· 2 days ago

     Pharmaceutical Intellidex Index is comprised of stocks of U.S. pharmaceutical companies. It is...

4. • Why Investors Are Eyeing AbbVie Inc (ABBV): The Key Drivers of M

     Guru Focus· 2 days ago

     AbbVie Inc (ABBV, Financial) has recently captured the attention of investors and financial analysts alike, thanks to its solid financial performance and promising growth ...

5. • 

     TEVA Stock Rises 135% in a Year: What's Driving the Recovery?

     Zacks· 1 day ago

     Teva Pharmaceutical Industries Limited’s (TEVA Quick QuoteTEVA - Free Report) revenues have suffered...

6. • 

     3 Dividend Stocks You May Want To Double Down On

     Benzinga via Yahoo Finance· 20 hours ago

     Sometimes, misunderstood stocks benefit investors. Savvy investors can capitalize when a stock is incorrectly perceived as weak during a recession....

7. • 2023 Highlights in Canadian Life Sciences IP and Regulatory Law | JD Supra

     JD Supra· 5 days ago

     The FC found the third patent claiming an aqueous formulation of adalimumab valid, with infringement conceded, but declined...public interest as switching to other biosimilars could cause increased ...

8. • OSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating...

     Benzinga· 5 hours ago

     OSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating FR104/VEL-101 Immunotherapy in Renal Transplant At the American Transplant Congress 2024 (June 1-5 Philadelphia) Nantes,

9. • 

     Insmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data

     Zacks via Yahoo Finance· 7 days ago

     Data from a late-stage study shows that treatment with Insmed's (INSM) brensocatib reduced episodes...

10. • 

      Here are the organizations that Ken Paxton targeted using consumer protection laws

      The Texas Tribune· 6 days ago

      Also, sign up for The Brief, our daily newsletter that keeps readers up to speed on the most...